Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: T32 CA229102
National Institutes of Health
Grant: 5T32GM008361
National Institutes of Health
Grant: P30 AR048311
National Institutes of Health
Grant: P30 AI27667
National Institutes of Health
Grant: P30 CA013148
Sid Strong Foundation
Grant: N/A
FWCI
2.11
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals